echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Clin Gastroenterology H: Risk analysis of late recurrence of Crohn's disease after ileocecal resection under endoscopic remission

    Clin Gastroenterology H: Risk analysis of late recurrence of Crohn's disease after ileocecal resection under endoscopic remission

    • Last Update: 2021-06-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Crohn’s disease (CD) is a chronic disabling inflammatory bowel disease (IBD).
    Approximately half of patients require surgery in the first ten years after diagnosis, and one-third of patients require multiple procedures during the course of the disease.
    Bowel resection surgery
    .


    The Rutgeerts score can classify the severity of CD recurrence symptoms under endoscopic surgery after ileocecal resection, so as to judge the disease recurrence under endoscopic surgery


    Crohn’s disease (CD) is a chronic disabling inflammatory bowel disease (IBD).


     

    Researchers conducted a retrospective study in 3 inflammatory bowel disease (IBD) centers in France and Belgium.
    The trial was conducted from 2006 to 2016, and all CD patients (n=86) received a response.
    For blind resection, there was no endoscopic evidence of disease recurrence at baseline assessment (Rutgeerts score lower than i2)
    .


    Postoperative recurrence after baseline endoscopy was defined as at least one of the following: clinical recurrence, IBD-related hospitalization, intestinal injury, the need for endoscopic balloon dilatation anastomoses, and the need for repeated surgical treatment


     

    The median time between surgery and baseline endoscopy was 7 months (IQR, 5.
    7-9.
    5 months); 40 patients (46.
    5%) received drug prophylaxis during this period
    .


    Thirty-five patients (40.


    prevention

    Figure: Endoscopic remission of Crohn's disease in patients with late recurrence after ileocecal resection

    This study found that among CD patients treated by ileocecal resection, 40% of patients had late recurrence after a median follow-up time of 3.
    5 years.
    Although the initial endoscopic remission was achieved, it is still recommended after 18 months These patients are closely monitored for disease activity
    .

          This study found that among CD patients treated by ileocecal resection, 40% of patients had late recurrence after a median follow-up time of 3.
    5 years.
    Although the initial endoscopic remission was achieved, it is still recommended after 18 months These patients are closely monitored for disease activity
    .


     

     

    Original source:

    Lieven Pouillon.


    Risk of Late Postoperative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.